Article
A case-control study in NAT2 gene polymorphism studies in patients diagnosed with acute myeloid leukemia.
Acta biochimica Polonica - 16 Sept 2023
Farasani Abdullah
Abstract excerpt
INTRODUCTION: Acute myeloid leukemia (AML) is a clinically defined heterogeneous disease whose pathophysiology is currently unknown. The association of NAT2 acetylation profiles with human cancer risks, particularly with AML, was investigated in molecular epidemiological studies. Additionally, the NAT2 gene was carried out with acute lymphoid leukemia and other cancers. AIM: In this case-control study, C481T...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
